16 completed, 7 unknown, 6 recruiting, 2 active not recruiting. 35 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 35 | Completed 16, Unknown 7, Recruiting 6, Active not recruiting 2, Not yet recruiting 2, Terminated 2 |
| Phase 2 | 5 | Recruiting 2, Unknown 2, Completed 1 |
Follow placebo capsule: new trials by email Literature Review of placebo capsule trials Research Report on placebo capsule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FMT Capsules for rCDI Healthy donor stool, placebo capsule - Clostridioides Difficile Infection Recurrence, FMT | Phase 3 | Recruiting | Helsinki University Central Hospital | 76 | 2026-04-25 | 2026-04-29 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. ORMD-0801 8 mg, Placebo capsule, ORMD-0801 16 mg - Type 2 Diabetes Mellitus | Phase 3 | Not yet recruiting | Oramed, Ltd. | 300 | 2025-12-15 | 2025-08-03 |
| Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis Duloxetine, Placebo capsule - Biliary Disease | Phase 3 | Recruiting | Tanta University | 44 | 2025-03-10 | 2026-08-18 |
| Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins), placebo capsule - Acute Coronary Syndrome | Phase 3 | Not yet recruiting | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 400 | 2025-03-01 | 2025-02-25 |
| Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects Lifestyle Intervention, Dasatinib 100 MG, Quercetin 1000mg - Obesity, Healthy Lifestyle | Phase 2 / Phase 3 | Recruiting | Cedars-Sinai Medical Center | 160 | 2023-10-17 | 2026-03-18 |
| Melatonin for Prevention of Kidney Injury Melatonin, Placebo Capsule - Acute Kidney Injury, Adverse Drug Event | Phase 3 | Recruiting | Rutgers, The State University of New Jersey | 300 | 2023-06-05 | 2025-12-17 |
| Effects of Curcumin on Inflammation and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study Curcumin capsules 1 gm, Placebo capsule - Pediatric Patients Having Renal Failure and on Regular Hemodialysis | Phase 3 | Unknown | Ain Shams University | 30 | 2022-12-01 | 2022-11-28 |
| The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Ascorbic acid, Tocopherol, Placebo capsule - Restless Legs Syndrome, End Stage Renal Disease | Phase 3 | Unknown | King Abdulaziz University | 160 | 2022-11-01 | 2022-08-24 |
| A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) centanafadine capsule, placebo capsule - Attention Deficit/Hyperactivity Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 574 | 2022-07-11 | 2026-04-13 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C K-877 0.1 mg tablet, Fenofibrate 200 mg capsule, Placebo tablet - Hyperlipidemia | Phase 3 | Completed | Kowa Company, Ltd. | 353 | 2021-09-17 | 2025-05-23 |
| Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) T89 capsule, Placebo capsule - Acute Mountain Sickness (AMS) | Phase 3 | Completed | Tasly Pharmaceuticals, Inc. | 853 | 2021-07-21 | 2024-08-13 |
| A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients BPI-7711, Gefitinib, Placebo Tablet - NSCLC | Phase 3 | Unknown | Beta Pharma Shanghai | 369 | 2021-04-30 | 2024-08-07 |
| Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery Pregabalin 300 mg, Pregabalin 75 mg, Pregabalin 300 mg Placebo - Opioid Use | Phase 3 | Terminated | Hamilton Health Sciences Corporation | 17 | 2021-04-09 | 2022-09-10 |
| Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial Memantine Hydrochloride Oral Solution, Trazodone Hydrochloride oral solution, Placebo oral solution - Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Phase 2 / Phase 3 | Recruiting | University of Edinburgh | 1150 | 2020-02-27 | 2026-03-04 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria Reloxaliase, Placebo - Enteric Hyperoxaluria | Phase 3 | Terminated | Allena Pharmaceuticals | 92 | 2019-08-26 | 2022-06-10 |
| Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina T89 capsule, Placebo capsule - Chronic Stable Angina Pectoris | Phase 3 | Recruiting | Tasly Pharmaceuticals, Inc. | 765 | 2019-08-01 | 2025-04-09 |
| GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease COR388 capsule, Placebo capsule - Alzheimer Disease | Phase 2 / Phase 3 | Completed | Cortexyme Inc. | 643 | 2019-03-28 | 2023-02-23 |
| Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer Pamiparib capsule, Placebo capsule - Ovarian Cancer | Phase 3 | Active not recruiting | BeiGene | 224 | 2018-05-14 | 2026-03-16 |
| Gabapentin Reduces Opioid Use Postoperatively ("GROUP Study") Gabapentin, placebo - Pelvic Organ Prolapse | Phase 3 | Unknown | Mount Sinai Hospital, Canada | 44 | 2017-01-01 | 2017-02-14 |
Showing 20 of 35. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (4) · Fibromyalgia (3) · Pain (3) · Acute Coronary Syndrome (1) · Acute Kidney Injury (1) · Altitude Sickness (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Angina Pectoris (1) · Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · Candidiasis, Vulvovaginal (1) · Carcinoma, Non-Small-Cell Lung (1) · Clostridium Infections (1) · Diabetes Mellitus, Type 2 (1)
Daiichi Sankyo (4) · Rhodes Pharmaceuticals, L.P. (3) · Susan Carlson, PhD (2) · Tasly Pharmaceuticals, Inc. (2) · Ain Shams University (1) · Allena Pharmaceuticals (1) · BeiGene (1) · Beta Pharma Shanghai (1) · Cedars-Sinai Medical Center (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Cortexyme Inc. (1) · Eli Lilly and Company (1) · Hamilton Health Sciences Corporation (1) · Helsinki University Central Hospital (1) · King Abdulaziz University (1)
United States (19) · Canada (9) · China (7) · France (6) · Poland (6) · United Kingdom (6) · Austria (5) · Germany (5) · Netherlands (5) · Spain (5) · Australia (4) · Italy (4) · Mexico (4) · Belgium (3) · Romania (3)
Henry H Sun, PhD, MD (2) · Joseph Reiz (2) · Susan E Carlson, PhD (2) · Andre Lamy, MD, MHSc (1) · Danny Lovatsis, MD (1) · David Clark, MD (1) · Herbert Kiss, Prof. (1) · Jiang Quan, Doctor (1) · John Colombo, PhD (1) · John Eikelboom, MD (1) · Karen Smith, MD (1) · Li Kai, doctor (1)
PMID 31284771, PMID 31004139, PMID 20131255, PMID 22297243, PMID 23346990, PMID 23426033, PMID 23803884, PMID 25302772, PMID 25500337, PMID 26299520, PMID 27041409, PMID 27362506, PMID 27499448, PMID 27637340, PMID 27884184, PMID 29381793, PMID 29564507, PMID 30207920, PMID 30311214, PMID 30392575, PMID 30794304, PMID 31229240, PMID 31467033, PMID 32755241, PMID 33289960, PMID 34057707, PMID 34637343, PMID 34714112, PMID 35798516, PMID 36001000, PMID 36647114, PMID 36725099, PMID 36971690, PMID 39098034, PMID 39307154, PMID 39914443, PMID 41342306, PMID 41845293, PMID 41924561, PMID 42084377, PMID 42132251, PMID 42779129
R01HD047315 (2), 2014 (1), 2018 (1), R01AG075684 (1)